AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 69 filers reported holding AKERO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,329,314 | +5.4% | 56,663 | +13.5% | 0.00% | – |
| Q1 2024 | $1,261,155 | +25.2% | 49,927 | +15.7% | 0.00% | – |
| Q4 2023 | $1,007,249 | -54.0% | 43,137 | -0.3% | 0.00% | -100.0% |
| Q3 2023 | $2,187,534 | +16.1% | 43,249 | +7.1% | 0.00% | 0.0% |
| Q2 2023 | $1,884,595 | +67.6% | 40,364 | +37.4% | 0.00% | – |
| Q1 2023 | $1,124,347 | +55.1% | 29,387 | +122.1% | 0.00% | – |
| Q4 2022 | $724,948 | +107.7% | 13,229 | +29.2% | 0.00% | – |
| Q3 2022 | $349,000 | +391.5% | 10,236 | +36.9% | 0.00% | – |
| Q2 2022 | $71,000 | -27.6% | 7,478 | +8.2% | 0.00% | – |
| Q1 2022 | $98,000 | -32.9% | 6,909 | 0.0% | 0.00% | – |
| Q4 2021 | $146,000 | -4.6% | 6,909 | +0.6% | 0.00% | – |
| Q3 2021 | $153,000 | +64.5% | 6,867 | +81.7% | 0.00% | – |
| Q2 2021 | $93,000 | +34.8% | 3,779 | +60.3% | 0.00% | – |
| Q1 2021 | $69,000 | +9.5% | 2,358 | -3.0% | 0.00% | – |
| Q4 2020 | $63,000 | -16.0% | 2,430 | 0.0% | 0.00% | – |
| Q3 2020 | $75,000 | +63.0% | 2,430 | +31.8% | 0.00% | – |
| Q2 2020 | $46,000 | +70.4% | 1,844 | +44.1% | 0.00% | – |
| Q1 2020 | $27,000 | +35.0% | 1,280 | +40.7% | 0.00% | – |
| Q4 2019 | $20,000 | +17.6% | 910 | +19.9% | 0.00% | – |
| Q3 2019 | $17,000 | – | 759 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 103,816 | $5,251,013 | 6.02% |
| Boxer Capital, LLC | 1,676,733 | $84,809,155 | 4.52% |
| Redmile Group, LLC | 1,769,684 | $89,510,617 | 4.26% |
| Ghost Tree Capital, LLC | 250,000 | $12,645,000 | 4.16% |
| Logos Global Management LP | 600,000 | $30,348,000 | 4.05% |
| COMMODORE CAPITAL LP | 565,000 | $28,577,700 | 3.34% |
| Yiheng Capital Management, L.P. | 1,221,674 | $61,792,271 | 3.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $10,116,000 | 3.07% |
| Atlas Venture Life Science Advisors, LLC | 359,251 | $18,170,915 | 2.81% |
| Perceptive Advisors | 1,619,425 | $81,910,517 | 2.73% |